New research evaluates clinical trials investigating post-acute COVID-19 syndrome treatment

In a recent article published in Clinical Microbiology and Infection, researchers reviewed all registered trials currently investigating potential treatment options for post-acute coronavirus disease 2019 (COVID-19) syndrome (PACS).

Immunoglobulin signature predicts risk of post-acute COVID-19 syndrome

Clinical Trials – Medisys Research

Paxlovid May Reduce Risk of Long Covid in Eligible Patients, Study Finds - The New York Times

VV116 versus Nirmatrelvir–Ritonavir for Oral Treatment of Covid-19

Pharmaceutics, Free Full-Text

Randomized Trial of Anticoagulation Strategies for Noncritically Ill Patients Hospitalized With COVID-19

Incidence of Epilepsy and Seizures Over the First 6 Months After a COVID-19 Diagnosis

New research evaluates clinical trials investigating post-acute COVID-19 syndrome treatment

Study Is Investigating Role of Pituitary Hormone Deficiency in Post-COVID Fatigue

Frontiers Therapeutic trials for long COVID-19: A call to action from the interventions taskforce of the RECOVER initiative

Delay or Avoidance of Medical Care Because of COVID-19–Related Concerns — United States, June 2020

Post-acute COVID-19 syndrome

IJMS, Free Full-Text

Anticoagulation in Patients With COVID-19: JACC Review Topic of the Week